<DOC>
	<DOCNO>NCT02322229</DOCNO>
	<brief_summary>The purpose study observe anatomical functional outcome ocriplasmin ( JETREAÂ® ) 6-month follow-up period .</brief_summary>
	<brief_title>Ocriplasmin Vitreomacular Traction/Symptomatic Vitreomacular Adhesion</brief_title>
	<detailed_description>Subjects recruit approximately 10 center Australia New Zealand .</detailed_description>
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Diagnosis VMT/sVMA , evidence focal VMT visible Spectral Domain Optical Coherence Tomography ( SDOCT ) . Read , sign , date Institutional Review Board/Ethics Committeeapproved inform consent form . Willing able attend study visit . Other protocolspecified inclusion criterion may apply . Women childbearing potential pregnant , test positive urine pregnancy test , intend become pregnant study period , breastfeeding , agreement use adequate birth control method prevent pregnancy throughout study . Hypersensitivity ocriplasmin JETREA excipients . Active suspect intraocular periocular infection either eye . Participation interventional clinical trial within 30 day prior baseline . Presence epiretinal membrane ( ERM ) central macula study eye . Broad VMT/sVMA &gt; 1500 micron study eye . History vitrectomy study eye . History laser photocoagulation macula study eye . Any relevant concomitant ocular condition study eye , opinion Investigator , could expect worsen require surgical intervention study period . Macular hole &gt; 400 micron diameter study eye . High myopia study eye . Pseudoexfoliation , Marfan 's syndrome , phacodonesis , find study eye , Investigator 's opinion , suggest lens/zonular instability . Aphakia study eye . History retinal detachment study eye . Recent ocular surgery ocular injection study eye within past 90 day ( include laser therapy ) . Proliferative diabetic retinopathy ischemic retinopathy study eye . Retinal vein occlusion study eye . Exudative agerelated macular degeneration ( AMD ) study eye . Vitreous hemorrhage study eye . Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>VMT</keyword>
	<keyword>sVMA</keyword>
	<keyword>vitrectomy</keyword>
	<keyword>ocriplasmin</keyword>
</DOC>